Immunology & Autoimmune
Part of Biotech - Drug Development
 JNJ | Johnson & Johnson | $0.6t | $255.69 | -0.3% | 11.6K |
 ABBV | ABBVIE INC. | $443.4b | $242.83 | -0.4% | 9.3K |
 AMGN | Amgen Inc | $207.9b | $404.18 | 0.0% | 5.0K |
 BMY | Bristol-Myers Squibb Co. | $133.4b | $64.06 | -0.2% | 6.1K |
 REGN | Regeneron Pharmaceuticals Inc | $78.2b | $772.04 | 0.0% | 168 |
 ROIV | Roivant Sciences Ltd. Common Shares | $24.1b | $36.01 | 0.0% | 16.8K |
 APGE | Apogee Therapeutics, Inc. Common Stock | $10.1b | $134.65 | 0.0% | 10 |
 PTGX | Protagonist Therapeutics, Inc | $8.5b | $146.87 | 0.0% | 1.2K |
 SYRE | Spyre Therapeutics, Inc. Common Stock | $8.2b | $105.21 | 0.0% | 4.5K |
 IMVT | Immunovant, Inc. Common Stock | $7.9b | $40.20 | 0.0% | 19.1K |
 IBRX | ImmunityBio, Inc. Common Stock | $7.5b | $7.46 | 0.0% | 85.4K |
 TGTX | TG Therapeutics, Inc. | $7.1b | $50.09 | 0.0% | 3.8K |
 DNTH | Dianthus Therapeutics, Inc. Common Stock | $5.8b | $110.33 | 0.0% | 1.1K |
 ORKA | Oruka Therapeutics, Inc. Common Stock | $5.7b | $98.57 | 0.0% | 1.3K |
 APLS | Apellis Pharmaceuticals, Inc. Common Stock | $5.2b | $41.04 | +0.0% | 68.6M |
 ALMS | Alumis Inc. Common Stock | $3.6b | $28.08 | 0.0% | 41 |
 RCUS | Arcus Biosciences, Inc. | $3.5b | $29.11 | +1.2% | 1.4K |
 ARQT | Arcutis Biotherapeutics, Inc. Common Stock | $3.4b | $26.83 | 0.0% | 2.0K |
 CLDX | Celldex Therapeutics, Inc | $3.0b | $41.74 | 0.0% | 466 |
 NKTR | Nektar Therapeutics | $2.4b | $74.38 | 0.0% | 4.1K |
 VERA | Vera Therapeutics, Inc. Class A Common Stock | $2.3b | $32.95 | 0.0% | 273.0K |
 BHVN | Biohaven Ltd. | $2.0b | $14.70 | 0.0% | 420 |
 ZBIO | Zenas BioPharma, Inc. Common Stock | $2.0b | $32.68 | 0.0% | 259 |
 ADMA | ADMA Biologics, Inc. | $2.0b | $10.05 | 0.0% | 15.8K |
 AUPH | Aurinia Pharmaceuticals Inc | $1.9b | $16.22 | 0.0% | 1.0K |
 SEPN | Septerna, Inc. Common Stock | $1.6b | $40.22 | 0.0% | 30 |
 FBRX | Forte Biosciences, Inc. Common Stock | $1.6b | $76.81 | 0.0% | 6.4K |
 ANAB | AnaptysBio, Inc. Common Stock | $1.6b | $55.05 | 0.0% | 36.3K |
 MLTX | MoonLake Immunotherapeutics Class A Ordinary Shares | $1.5b | $18.49 | 0.0% | 2.0K |
 XNCR | Xencor, Inc. | $1.4b | $20.35 | 0.0% | 6.3K |
 JBIO | Jade Biosciences, Inc. Common Stock | $1.2b | $22.66 | 0.0% | 21.9K |
 CRVS | Corvus Pharmaceuticals, Inc. | $1.1b | $13.09 | 0.0% | 10.3K |
 CGEM | Cullinan Therapeutics, Inc. Common Stock | $1.0b | $18.23 | 0.0% | 336 |
 AVTX | Avalo Therapeutics, Inc. Common Stock | $1.0b | $18.87 | 0.0% | 3.2K |
 ANNX | Annexon, Inc. Common Stock | $0.8b | $5.68 | 0.0% | 1.2K |
 DBVT | DBV Technologies S.A. | $0.8b | $13.95 | 0.0% | 3.0K |
 ACRS | Aclaris Therapeutics, Inc. | $0.7b | $6.14 | 0.0% | 2.4K |
 STTK | Shattuck Labs, Inc. Common Stock | $0.7b | $7.35 | 0.0% | 314 |
 RIGL | Rigel Pharmaceuticals Inc. (New) | $0.7b | $39.99 | 0.0% | 653 |
 CLYM | Climb Bio, Inc. Common Stock | $0.7b | $14.22 | 0.0% | 3.4K |
 IMMX | Immix Biopharma, Inc. Common Stock | $0.6b | $10.28 | 0.0% | 39.2K |
 ZURA | Zura Bio Limited Class A Ordinary Shares | $0.5b | $5.83 | 0.0% | 772 |
 QTTB | Q32 Bio Inc. Common Stock | $450.5m | $16.64 | 0.0% | 1.9K |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $443.8m | $8.03 | 0.0% | 903 |
 CABA | Cabaletta Bio, Inc. Common Stock | $437.0m | $2.79 | 0.0% | 3.6K |
 EVMN | Evommune, Inc. | $405.2m | $13.81 | -1.0% | 2.1K |
 ENTA | Enanta Pharmaceuticals, Inc | $366.4m | $13.63 | 0.0% | N/A |
 IPSC | Century Therapeutics, Inc. Common Stock | $364.3m | $1.93 | 0.0% | 1.6K |
 UPB | Upstream Bio, Inc. Common Stock | $349.4m | $6.99 | 0.0% | 29 |
 PALI | Palisade Bio, Inc. Common Stock | $337.1m | $2.08 | 0.0% | 9.1K |